<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="205">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 08, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00483145</url>
  </required_header>
  <id_info>
    <org_study_id>KF-01-328309</org_study_id>
    <nct_id>NCT00483145</nct_id>
  </id_info>
  <brief_title>Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea</brief_title>
  <official_title>Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <authority>Denmark: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye
      laser-mediated photodynamic therapy for acne vulgaris and rosacea.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind</study_design>
  <number_of_arms>2</number_of_arms>
  <condition>Acne Vulgaris and Rosacea</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Long-pulsed dye laser (Candela)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)</intervention_name>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long-pulsed dye laser</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inflammatory acne and rosacea

          -  Skin types I-IV

        Exclusion Criteria:

          -  Patients younger than 18 years

          -  Skin types V and VI

          -  Topical and systemic conventional acne treatments
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Merete Hædersdal</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <lastchanged_date>June 2, 2008</lastchanged_date>
  <firstreceived_date>June 4, 2007</firstreceived_date>
  <responsible_party>
    <name_title>Merete Hædersdal</name_title>
    <organization>Bispebjerg Hospital</organization>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acne Vulgaris</mesh_term>
    <mesh_term>Rosacea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aminolevulinic Acid</mesh_term>
    <mesh_term>Methyl 5-aminolevulinate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
